Refining clinical trial composite outcomes: An application to the assessment of the safety and efficacy of a new thrombolytic-3 (ASSENT-3) trial

American Heart Journal

Volumn 161, Issue 5, 2011, Pages 848-854

  Armstrong, Paul W ^a   Westerhout, Cynthia M ^a   Van De Werf, Frans ^b   Califf, Robert M ^c   Welsh, Robert C ^a   Wilcox, Robert G ^d   Bakal, Jeffrey A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ENOXAPARIN; HEPARIN; TENECTEPLASE;

ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CLINICAL ASSESSMENT; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 79955916492     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.12.026     Document Type: Article

References (27)

1. M.S. Lauer, and E.J. Topol Clinical trials-multiple treatments, multiple end points, and multiple lessons J Am Med Assoc 289 2003 2575 2577 (Pubitemid 37430160)
2. J. Loscalzo Clinical trials in cardiovascular medicine in an era of marginal benefit, bias, and hyperbole Circulation 112 2005 3026 3029 (Pubitemid 43113430)
3. N. Freemantle, M. Calvert, and J. Wood Composite outcomes in randomized trials: greater precision but with greater uncertainty? J Am Med Assoc 289 2003 2554 2559 (Pubitemid 37430157)
4. E. Lim, A. Brown, and A. Helmy Composite outcomes in cardiovascular research: a survey of randomized trials Ann Int Med 149 2008 612 617
5. M.S. Sabatine, C.P. Cannon, and C.M. Gibson Braunwald E for the CLARITY-TIMI 28 investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation New Engl J Med. 352 2005 1179 1189 (Pubitemid 40397259)
6. W.J. Cantor, D. Fitchett, and B. Borgundvaag Routine early angioplasty after fibrinolysis for acute myocardial infarction New Engl J Med 360 2009 2705 2718
7. R.M. Califf, L. Harrelson-Woodlief, and E.J. Topol Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials Circulation 82 1990 1847 1853 (Pubitemid 20367987)
8. E.J. Topol, P.W. Armstrong, and F. Van de Werf Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion J Am Coll Cardiol 19 1992 1123 1128
9. P.P. Glasziou, R.J. Simes, and R.D. Gelber Quality adjusted survival analysis Stat Med 9 1990 1259 1276 (Pubitemid 20361738)
10. ASSENT-3 Investigators Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomized trial in acute myocardial infarction Lancet 358 2001 605 613
11. P.W. Armstrong, A. Gershlick, and P. Goldstein The strategic reperfusion early after myocardial infarction (STREAM) study Am Heart J 160 2010 30 35 e1
12. J.D. Neaton, D.N. Wentworth, and F. Rhame Methods of studying interventions: considerations in choice of a clinical endpoint for AIDS clinical trials Stat Med 13 1994 2107 2125 (Pubitemid 24330394)
13. G. Cordoba, L. Schwartz, and S. Woloshin Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review BMJ c3920 2010 341
14. E.J. Topol, R.M. Califf, and F. Van de Werf Perspectives on large-scale cardiovascular clinical trials for the new millennium Circulation 95 1997 1072 1082 (Pubitemid 27091555)
15. R.M. Califf, E.J. Topol, and R.S. Stack Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction-phase 5 randomized trial. TAMI Study Group Circulation 83 1991 1543 1556
16. E. Braunwald, C.P. Cannon, and C.H. McCabe An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point Circulation 86 1992 683 687
17. T.M. Thernau, and P.M. Grambsch Multiple events per subject and frailty models K. Dietz, M. Gail, K. Krickeberg, J. Samet, A. Tsiatis, Modeling survival data: extending the Cox model 2000 Springer-Verlag New York (NY) 169 259
18. C. Metcalfe, and S.G. Thompson Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: should it be applied to a recurrent events outcome? Stat Methods Med Res 16 2007 103 122 (Pubitemid 46656627)
19. L.J. Wei, and D.V. Glidden An overview of statistical methods for multiple failure time data in clinical trials Stat Med 16 1997 833 839
20. L.J. Wei, D.Y. Lin, and L. Weissfeld Regression analysis of multivariate incomplete failure time data by modeling marginal distributions J Am Stat Assoc 84 1989 1065 1073
21. The Optimising Analysis of Stroke Trials (OAST) Collaboration Calculation of sample size for stroke trials assessing functional outcome: comparison of binary and ordinal approaches Int J Stroke 3 2008 78 84
22. E. Brittain, J. Palensky, and J. Blood Blinded subjective rankings as a method of assessing treatment effect: a large sample example from the Systolic Hypertension in the Elderly Program (SHEP) Stat Med 16 1997 681 693 (Pubitemid 27141995)
23. D. Follmann, J. Wittes, and J.A. Cutler The use of subjective rankings in clinical trials with an application to cardiovascular disease Stat Med 11 1992 427 437
24. P.W. Armstrong, L.K. Newby, and C.B. Granger Lessons learned from a clinical trial Circulation 110 2004 3610 3614 (Pubitemid 39612579)
25. K. Thygesen, J.S. Alpert, H.D. White on behalf of the joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction Circulation 116 2007 2634 2653 (Pubitemid 350182388)
26. S.V. Rao, J.G. Jollis, and R.A. Harrington Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes J Am Med Assoc 292 2004 1555 1562 (Pubitemid 39314961)
27. J.W. Eikelboom, S.R. Mehta, and S.S. Anand Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782 (Pubitemid 44268228)